IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Year: 2010
Type: article
Study design: Observational Study
Source: Neurology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2104669585
